6x3 Crossover, Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers

• Status: Completed
• Trial end date: 2020-01-02
• Target enrollment: 0
• Participant gender: All

Summary

A Randomized, Open Label, Single Subcutaneous Dose 6x3 Crossover Study to Investigate the Relative Bioavailability, Safety and Tolerability among Different Eutropin Formulations in Healthy Volunteers

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: LG Chem

Criteria

Inclusion Criteria:

• Healthy volunteers between the ages of 19 or more and less than 40 years (19 =< age < 40) on the day of screening

• Negative findings in serum / urine hCG test or Subjects who are not pregnant or lactating in women

Exclusion Criteria:

• Administered other drug(s) in other clinical study within 180 days prior to the day of screening